Opioid Use Disorder Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-03-11　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 6,303.4 Mn
2033 年預估規模: USD 9,860.2 Mn
年複合成長率 CAGR: 9.4%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-03-11頁數 168報告編號 CMI4597

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Opioid Use Disorder Market, By Product Type (Buprenorphine (Oral, Parenteral, Others), Naloxone (Parenteral and Others (Nasal Spray, etc.)), Naltrexone (Oral and Parenteral), Combination Drugs, and Methadone), By Route of Administration (Parenteral (Extended release Injection for Subcutaneous, Intramuscular), Oral (Sublingual Tablet, Sublingual Film, Suspension), and Others), By Dosage Form (Injections, Sublingual film, Sublingual or Buccal, Tablet, Suspension, and Others), By Availability (Prescription and Over the Counter), By Brand (Sublocade, Suboxone, Brixadi, Vivitrol, Zubsolv, NARCAN, and Others), By Age Group (Adult and Children), By Type (Branded and Generic), By Indication (Opioid Addiction and Pain Management (Acute, Chronic)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global opioid use disorder market is estimated to be valued at USD 6,303.4 Mn in 2026 and is expected to reach USD 9,860.2 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033. The global opioid use disorder market represents a critical healthcare segment addressing one of the most pressing public health crises of the modern era. Opioid use disorder is characterized as a chronic medical condition involving the compulsive use of opioids despite harmful consequences, affecting millions of individuals worldwide and imposing substantial socioeconomic burdens on healthcare systems, families, and communities. The market encompasses various therapeutic interventions including medication-assisted treatment (MAT) options such as methadone, buprenorphine, and naltrexone, alongside comprehensive behavioral therapies and support services. With opioid-related overdoses claiming hundreds of thousands of lives globally and addiction rates continuing to escalate, the demand for effective treatment solutions has intensified significantly. The market has witnessed substantial growth driven by increasing awareness about evidence-based treatments, government initiatives promoting accessible healthcare, and the destigmatization of addiction as a legitimate medical condition requiring professional intervention. Healthcare providers, pharmaceutical companies, and policymakers are collectively working to develop innovative treatment modalities, expand access to care, and implement harm reduction strategies. The integration of digital health technologies, telemedicine platforms, and personalized treatment approaches has further transformed the landscape, offering new opportunities for patient engagement and treatment optimization in addressing this complex disorder. Market Dynamics The global opioid use disorder market is primarily driven by the escalating prevalence of opioid addiction worldwide, with prescription opioid misuse and illicit drug consumption reaching epidemic proportions across developed and developing nations. Government initiatives and policy reforms promoting evidence-based treatment approaches, including expanded Medicaid coverage and the elimination of prior authorization requirements for MAT, have significantly boosted market growth. The increasing recognition of addiction as a treatable medical condition rather than a moral failing has reduced stigma and encouraged more individuals to seek professional help. Technological advancements in treatment delivery, including telemedicine platforms, mobile health applications, and remote monitoring systems, have improved accessibility and treatment adherence, particularly in underserved rural areas. However, the market faces substantial restraints including persistent stigma surrounding addiction treatment, limited healthcare infrastructure in certain regions, and inadequate insurance coverage for comprehensive treatment programs. Regulatory complexities and stringent prescribing requirements for certain medications create barriers for healthcare providers and patients. The shortage of qualified addiction specialists and treatment facilities, particularly in rural areas, significantly limits access to care. Additionally, the high cost of long-term treatment programs and the lack of standardized treatment protocols across different healthcare systems pose challenges to market expansion. Nevertheless, significant opportunities exist through the development of novel therapeutic interventions, including long-acting injectable formulations and abuse-deterrent medications. The growing emphasis on integrated care models combining medical treatment with behavioral health services presents substantial growth potential. Public-private partnerships and increased funding for addiction research and treatment infrastructure development offer promising avenues for market expansion. Key Features of the Study • This report provides in-depth analysis of the global opioid use disorder market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global opioid use disorder market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Indivior, Braeburn, Camurus, Alkermes, Emergent BioSolutions, Orexo, Hikma Pharmaceuticals, Dr Reddy’s Laboratories, Alvogen, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Viatris, Teva Pharmaceuticals, Sandoz, and Kaléo • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global opioid use disorder market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid use disorder market Market Segmentation • Product Type Insights (Revenue, USD Mn, 2021 - 2033) o Buprenorphine  Oral  Parenteral  Others o Naloxone  Parenteral  Others o Naltrexone  Oral  Parenteral o Combination Drugs o Methadone • Route of Administration Insights (Revenue, USD Mn, 2021 - 2033) o Parenteral  Extended-release Injection for Subcutaneous  Intramuscular o Oral  Sublingual Tablet  Sublingual Film  Suspension o Others • Dosage Form Insights (Revenue, USD Mn, 2021 - 2033) o Injections o Sublingual film o Sublingual or Buccal o Tablet o Suspension o Others • Availability Insights (Revenue, USD Mn, 2021 - 2033) o Prescription o Over the Counter • Brand Insights (Revenue, USD Mn, 2021 - 2033) o Sublocade o Suboxone o Brixadi o Vivitrol o Zubsolv o NARCAN o Others • Age Group Insights (Revenue, USD Mn, 2021 - 2033) o Adult o Children • Type Insights (Revenue, USD Mn, 2021 - 2033) o Branded o Generic • Indication Insights (Revenue, USD Mn, 2021 - 2033) o Opioid Addiction o Pain Management o Acute o Chronic • Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Indivior o Braeburn o Camurus o Alkermes o Emergent BioSolutions o Orexo o Hikma Pharmaceuticals o Dr Reddy’s Laboratories o Alvogen o Sun Pharmaceutical Industries o Amneal Pharmaceuticals o Viatris o Teva Pharmaceuticals o Sandoz o Kaléo

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Opioid Use Disorder Market, By Product Type  Global Opioid Use Disorder Market, By Route of Administration  Global Opioid Use Disorder Market, By Dosage Form  Global Opioid Use Disorder Market, By Availability  Global Opioid Use Disorder Market, By Brand  Global Opioid Use Disorder Market, By Age Group  Global Opioid Use Disorder Market, By Type  Global Opioid Use Disorder Market, By Indication  Global Opioid Use Disorder Market, By Distribution Channel  Global Opioid Use Disorder Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Driver o Restraint o Opportunity o Impact Analysis o Key Developments o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Merger and Acquisition Scenario o Industry Trends 4. Global Opioid Use Disorder Market, By Product Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Buprenorphine  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oral o Parenteral o Others o Naloxone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Parenteral o Others o Naltrexone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Oral o Parenteral o Combination Drugs  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Methadone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Opioid Use Disorder Market, By Route of Administration, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Parenteral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Extended-release Injection for Subcutaneous o Intramuscular o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Sublingual Tablet o Sublingual Film o Suspension o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Opioid Use Disorder Market, By Dosage Form, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Injections  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Sublingual film  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Sublingual or Buccal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Tablet  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Suspension  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Opioid Use Disorder Market, By Availability, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Prescription  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Over the Counter  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Opioid Use Disorder Market, By Brand, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Sublocade  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Suboxone  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Brixadi  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Vivitrol  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Zubsolv  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o NARCAN  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Opioid Use Disorder Market, By Age Group, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Adult  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Children  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global Opioid Use Disorder Market, By Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Branded  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Generic  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 11. Global Opioid Use Disorder Market, By Indication, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Opioid Addiction  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Pain Management  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Acute o Chronic 12. Global Opioid Use Disorder Market, By Distribution Channel, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 13. Global Opioid Use Disorder Market, By Region, 2021 - 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Channel, 2021 - 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Availability, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 14. Competitive Landscape o Indivior  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Braeburn  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Camurus  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Alkermes  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Emergent BioSolutions  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Orexo  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hikma Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Dr Reddy’s Laboratories  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Alvogen  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sun Pharmaceutical Industries  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Amneal Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Viatris  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Teva Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sandoz  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Kaléo  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 15. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 16. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Opioid Use Disorder Market' - Global forecast to 2033

提及公司

IndiviorBraeburnCamurusAlkermesEmergent BioSolutionsOrexoHikma PharmaceuticalsDr Reddy’s LaboratoriesAlvogenSun Pharmaceutical IndustriesAmneal PharmaceuticalsViatrisTeva PharmaceuticalsSandozKaléo

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們